BARD1AG SA Revenue and Competitors
Estimated Revenue & Valuation
- BARD1AG SA's estimated annual revenue is currently $4.5M per year.
- BARD1AG SA's estimated revenue per employee is $155,000
Employee Data
- BARD1AG SA has 29 Employees.
BARD1AG SA's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | R&D Director | Reveal Email/Phone |
3 | Research And Development Manager | Reveal Email/Phone |
4 | Strategic Technology Advisor | Reveal Email/Phone |
BARD1AG SA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is BARD1AG SA?
ABOUT BARD1 LIFE SCIENCES LTD BARD1 Life Sciences Ltd (ASX:BD1) (BARD1 or the Company) is a leading Australian-based medical diagnostics company with an innovative portfolio of diagnostic technologies and products. The Company is focused on the development and commercialisation of best in class lifesaving diagnostic solutions for health care professionals and patients. The cancer diagnostics portfolio includes the marketed hTERT test to aid in the diagnosis of bladder cancer and tests in development for ovarian, breast, lung, prostate and pancreatic cancers.
keywords:N/A
N/A
Total Funding
29
Number of Employees
$4.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Notting Hill
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 45 | 55% | N/A |
#2 | $5M | 55 | -8% | N/A |
#3 | N/A | 70 | 52% | N/A |
#4 | $17.8M | 87 | 30% | N/A |
#5 | $21.2M | 101 | 0% | N/A |